Bodymine
The computed 12-month bankruptcy probability of Bodymine is 0.2% (very low). The 2025 annual accounts show equity of €74k and a net result of €72k. Its solvency ranks better than 44% of 2208 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €74k |
| Net result | €72k |
| Better than sector | 44% |
| Active | 2 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 48.2% | 58.2% | |
| Net result | €72k | €60k | |
| Equity | €74k | €74k | |
| Gross operating margin | €86k | €96k | |
| Total assets | €154k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €85k |
| Net profit | €72k |
| Cash flow | €77k |
| Staff costs | - |
| Income taxes | €7k |
| Dividends | - |
| Total assets | €154k |
| Equity | €74k |
| Debt | €80k |
| of which ≤ 1y | €17k |
| of which > 1y | €63k |
| Working capital | €57k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 4.38 |
| Quick ratio | 4.38 |
| Working capital ratio | 36.9% |
| Solvency | 48.2% |
| Debt / equity | 1.08 |
| Long-term debt ratio | 0.85 |
| Interest coverage | 146.81 |
| Gross margin | - |
| Net margin | - |
| ROA | 46.9% |
| ROE | 97.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €154k |
| Fixed assets | 21/28 | €80k |
| Tangible fixed assets | 22/27 | €80k |
| Current assets | 29/58 | €74k |
| Amounts receivable within one year | 40/41 | €2k |
| Cash & bank | 54/58 | €72k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €154k |
| Equity | 10/15 | €74k |
| Contributions / capital | 10/11 | €2k |
| Reserves | 13 | €72k |
| Amounts payable | 17/49 | €80k |
| Amounts payable after one year | 17 | €63k |
| Amounts payable within one year | 42/48 | €17k |
| Trade debts payable within one year | 44 | €132 |
| Income statement | ||
| Gross operating margin | 9900 | €86k |
| Operating result | 9901 | €80k |
| Financial income | 75 | €13 |
| Financial charges | 65 | €579 |
| Result before taxes | 9903 | €79k |
| Income taxes | 67/77 | €7k |
| Net result for the period | 9904 | €72k |
| Result to be appropriated | 9905 | €72k |
| NACE primary | Human health(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 18-03-2024 |
| Status | Active |
| Postal code | 2230 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13013F0608/00R000 | Flanders | 988 m² | 1 · 152 m² | 7.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
12-04-2024 2 directors appointed
- Huybs Ward, Niet-statutair bestuurder
- Huybs Lennert, Niet-statutair bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "niet_statutair",
"person": {
"rrn": "02.11.21-135.62",
"name": "Huybs Ward",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2024-04-01",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "niet_statutair",
"person": {
"rrn": "02.11.21-141.56",
"name": "Huybs Lennert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2024-04-01",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-04-12",
"filing_date": "2024-04-03",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-03-29",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1007.262.153",
"name_full": "Bodymine",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Huybs Tom",
"org_rep_person_name": null,
"person_role_at_subject": "niet-statutaire bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Bodymine |